Foghorn Therapeutics Q1 EPS $(0.30) Beats $(0.31) Estimate, Sales $5.95M Beat $5.82M Estimate

Author: Benzinga Newsdesk | May 14, 2025 06:10am
Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 49.15 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $5.95 million which beat the analyst consensus estimate of $5.82 million by 2.34 percent. This is a 17.86 percent increase over sales of $5.05 million the same period last year.

Posted In: FHTX